APA citiranje

Vaught, D. B., Merkel, A. R., Lynch, C. C., Edwards, J., Tantawy, M. N., Hilliard, T., . . . Brantley‐Sieders, D. (2021). EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease. JBMR Plus.

Citação norma Chicago

Vaught, David B., et al. "EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease." JBMR Plus 2021.

MLA citiranje

Vaught, David B., et al. "EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease." JBMR Plus 2021.